Cargando…
Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569969/ https://www.ncbi.nlm.nih.gov/pubmed/34736482 http://dx.doi.org/10.1186/s13024-021-00490-z |
| _version_ | 1784594748226404352 |
|---|---|
| author | Gandy, Sam Knopman, David S. Sano, Mary |
| author_facet | Gandy, Sam Knopman, David S. Sano, Mary |
| author_sort | Gandy, Sam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8569969 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85699692021-11-08 Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA Gandy, Sam Knopman, David S. Sano, Mary Mol Neurodegener Commentary BioMed Central 2021-11-04 /pmc/articles/PMC8569969/ /pubmed/34736482 http://dx.doi.org/10.1186/s13024-021-00490-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Commentary Gandy, Sam Knopman, David S. Sano, Mary Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA |
| title | Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA |
| title_full | Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA |
| title_fullStr | Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA |
| title_full_unstemmed | Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA |
| title_short | Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA |
| title_sort | talking points for physicians, patients and caregivers considering aduhelm® infusion and the accelerated pathway for its approval by the fda |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569969/ https://www.ncbi.nlm.nih.gov/pubmed/34736482 http://dx.doi.org/10.1186/s13024-021-00490-z |
| work_keys_str_mv | AT gandysam talkingpointsforphysicianspatientsandcaregiversconsideringaduhelminfusionandtheacceleratedpathwayforitsapprovalbythefda AT knopmandavids talkingpointsforphysicianspatientsandcaregiversconsideringaduhelminfusionandtheacceleratedpathwayforitsapprovalbythefda AT sanomary talkingpointsforphysicianspatientsandcaregiversconsideringaduhelminfusionandtheacceleratedpathwayforitsapprovalbythefda |